This paper was commissioned for the aids2031 Science and Technology Working Group as part of a series of working papers under the aids2031 initiative. This paper explores issues that could be included in a future research agenda to enhance drug development for HIV/AIDS, including the optimal time to begin antiretroviral therapy, appropriate dosing of antiretrovirals, possible implications of HIV on advanced aging, and an exploration of recent challenges in drug development.
Emerging Trends in HIV Pathogenesis and Treatment
179.3 KB PDF
Hard copies are not available.